News

UBS lowered the firm’s price target on DocuSign (DOCU) to $85 from $90 and keeps a Neutral rating on the shares following the company’s user ...
Analysts fell to the sidelines weighing in on DocuSign (DOCU – Research Report) and KLA (KLAC – Research Report) with neutral ratings, ...